Heartburn Meds and Cancer: What Are the Risks?

The heartburn drug ranitidine -- more popularly known by the brand name Zantac -- may be prone to breaking down into a cancer-causing substance. Here's what you should know.

Trouble viewing this email? View as a Webpage Top Stories Heartburn Meds and Cancer: What Are the Risks? The heartburn drug ranitidine -- more popularly known by the brand name Zantac -- may be prone to breaking down into a cancer-causing substance. Here's what you should know. Read More   Personalized Diets: Does Your Microbiome Hold the Keys to Losing Pounds? Legionnaires' Cases in North Carolina Rise Cancer Risks Spur Calls to Replace Ethylene Oxide Billions of 'Microplastics' in Each Plastic Teabag FDA Approves New Pill for Type 2 Diabetes Low Vitamin D, Shorter Life? Expert Insights CDC Director on Vaping: 'We Shouldn't Assume Things Are Safe' What We Don't Know About CBD Could Hurt You 'Things That Get Me Through Bad Depression Days' Trending Videos The Truth About Intermittent Fasting Can This Blanket Help Ease Your Anxiety? ADVERTISEMENT ADVERTISEMENT WebMD.com   |  Mobile Apps  |  Unsubscribe     You are receiving this message because you registered with WebMD as rssproject471@gmail.com. If you did not register for WebMD please contact our Customer Care Team WebMD Privacy Policy © 2019 WebMD, LLC. All rights reserved. WebMD Office of Privacy | 1201 Peachtree Street, NE | Atlanta, GA 30361

Tweet

Postingan terkait:

— Monday, September 30, 2019 — Add Comment